Target Name: MIR548H3
NCBI ID: G100302287
Review Report on MIR548H3 Target / Biomarker Content of Review Report on MIR548H3 Target / Biomarker
MIR548H3
Other Name(s): hsa-miR-548h-5p | microRNA 548h-3 | MIR548H-3 | MicroRNA 548h-3 | hsa-mir-548h-3 | MIRN548H3

MIR548H3: A Drug Target / Disease Biomarker

MIR548H3 is a protein that is expressed in various tissues of the body, including the lungs, heart, kidneys, and intestines. It is a member of the immunoglobulin superfamily and is characterized by its five transmembrane伪2 heavy chains and a hinge region between them.

MIR548H3 has been identified as a potential drug target in the field of immunology due to its unique structure and the involvement of multiple signaling pathways. One of the most promising aspects of MIR548H3 is its ability to interact with a variety of different signaling pathways, including TGF-β, NF-kappa-B, and PI3K.

TGF-β is a transcription factor that plays a critical role in cell growth, differentiation, and survival. MIR548H3 has been shown to interact with TGF-β and has been proposed as a potential TGF-β inhibitor. This interaction between MIR548H3 and TGF-β has important implications for the development of TGF-β-related diseases, such as cancer.

NF-kappa-B is a signaling pathway that plays a role in inflammation, pain, and survival. MIR548H3 has been shown to interact with NF-kappa-B and has been proposed as a potential NF-kappa-B inhibitor. This interaction between MIR548H3 and NF-kappa-B has important implications for the development of NF-kappa-B-related diseases, such as neuroinflammatory diseases and cancer.

PI3K is a signaling pathway that plays a role in cell signaling, including the regulation of inflammation and pain. MIR548H3 has been shown to interact with PI3K and has been proposed as a potential PI3K inhibitor. This interaction between MIR548H3 and PI3K has important implications for the development of PI3K-related diseases, such as cancer and neuroinflammatory diseases.

In addition to its potential interactions with TGF-β, NF-kappa-B, and PI3K, MIR548H3 has also been shown to interact with a variety of other signaling pathways, including the PI3K/Akt signaling pathway. This interaction between MIR548H3 and PI3K/Akt has important implications for the development of PI3K/Akt-related diseases, such as cancer.

MIR548H3 has also been shown to play a role in the regulation of cellular processes, including cell adhesion, migration, and invasion. This suggests that MIR548H3 may be a useful target for the development of drugs that can modulate these processes and have potential therapeutic applications in a variety of diseases.

Despite the potential therapeutic applications of MIR548H3, it is still a relatively unstudied protein. There are currently few studies that have specifically investigated the effects of MIR548H3 and its potential as a drug target. However, these studies are promising and suggest that MIR548H3 may be a promising target for the development of new therapeutic drugs.

In conclusion, MIR548H3 is a protein that has been identified as a potential drug target due to its unique structure and the involvement of multiple signaling pathways. Further studies are needed to investigate the effects of MIR548H3 and its potential as a drug target.

Protein Name: MicroRNA 548h-3

The "MIR548H3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR548H3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR548H4 | MIR548H5 | MIR548I1 | MIR548I2 | MIR548I3 | MIR548I4 | MIR548J | MIR548K | MIR548L | MIR548M | MIR548N | MIR548O | MIR548O2 | MIR548P | MIR548Q | MIR548S | MIR548T | MIR548U | MIR548V | MIR548W | MIR548X | MIR548Y | MIR549A | MIR550A1 | MIR550A2 | MIR550A3 | MIR550B1 | MIR550B2 | MIR551A | MIR551B | MIR552 | MIR553 | MIR554 | MIR555 | MIR556 | MIR557 | MIR5571 | MIR5572 | MIR5579 | MIR558 | MIR5580 | MIR5581 | MIR5582 | MIR5583-1 | MIR5584 | MIR5585 | MIR5586 | MIR5587 | MIR5588 | MIR5589 | MIR559 | MIR5590 | MIR5591 | MIR561 | MIR562 | MIR563 | MIR564 | MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697 | MIR5698 | MIR5699 | MIR570 | MIR5700 | MIR5701-1 | MIR5701-2 | MIR5701-3 | MIR5702 | MIR5703 | MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG | MIR571 | MIR572